# Biomarkers of Synaptic Damage in Multiple Sclerosis

> **NCT03217396** · — · RECRUITING · sponsor: **Neuromed IRCCS** · enrollment: 300 (estimated)

## Conditions studied

- Multiple Sclerosis
- Parkinson Disease
- Amyotrophic Lateral Sclerosis
- Alzheimer Disease

## Interventions

- **PROCEDURE:** lumbar puncture

## Key facts

- **NCT ID:** NCT03217396
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-11-22
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03217396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03217396, "Biomarkers of Synaptic Damage in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03217396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*